LATEST NEWS

Rosneblatt web panel_I0A4721 2
Print Friendly

Rosenblatt advises WH Ireland and WG Partners (a division of Charles Stanley & Co Limited) on a conditional placing, subscription and open offer by Verona Pharma plc to raise up to £14m

07/03/2014

Rosenblatt has advised WH Ireland Limited and WG Partners (a division of Charles Stanley & Co. Limited) on a conditional placing, subscription and open offer by Verona Pharma plc to raise up to £14m.  WH Ireland and WG Partners were joint brokers to Verona Pharma on the fundraising and WH Ireland is the company’s nominated adviser.

Verona Pharma is a drug development company focused on the development of high value, “first-in-class” drugs for severe, specialist-treated respiratory diseases.

The placing, subscription and open offer are conditional on, amongst other things, shareholder approval at a general meeting convened for 24 March 2014.   

Nick Foss-Pedersen from Rosenblatt’s corporate team advised WH Ireland and WG Partners on the fund raising.

© Rosenblatt Solicitors 2017
Rosenblatt is authorised and regulated by the Solicitors Regulation Authority (SRA No. 00070109). The registered address and principal place of business is 9-13 St. Andrew Street, London EC4A 3AF.
You can access the rules by which we are regulated by following this link - www.sra.org.uk/solicitors/code-of-conduct.page. Rosenblatt is registered for Value Added Tax in the United Kingdom under registration number GB 523 0713 85.
  • contact

    To contact us please complete this form

e-Bulletins